BiolineRx
Signal active
Organization
Contact Information
Overview
BioLineRx is a clinical-stage, publicly traded (NASDAQ/ TASE: BLRX) biopharmaceutical development company based in Jerusalem, Israel. The Company develops products suitable for the pharmaceutical market satisfying an unmet medical need or exhibiting advantages over current therapies.
About
Industries
Biotechnology, Medical Device, Therapeutics, Oncology
Founded
2003
Employees
51-100
Headquarters locations
Asia
Social
N/A
Profile Resume
BiolineRx headquartered in Asia, operates in the Biotechnology, Medical Device, Therapeutics, Oncology sector. The company focuses on Biotechnology and has secured $68.5B in funding across 256 round(s). With a team of 51-100 employees, BiolineRx is actively contributing to advancements in Biotechnology. Their latest funding round, Post-IPO Equity - BiolineRx, raised $24.1M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
16
Investors
0
Lead Investors
0
Total Funding Amount
$267.7M
Details
0
BiolineRx has raised a total of $267.7M in funding over 0 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|
Investors
BiolineRx is funded by 18 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| BlackRock | - | FUNDING ROUND - BlackRock | 20.0M |
| Star Ventures | - | FUNDING ROUND - Star Ventures | 4.0M |
| BiolineRx | - | FUNDING ROUND - BiolineRx | 4.0M |
| Yehuda Zisapel | - | FUNDING ROUND - Yehuda Zisapel | 4.0M |
Recent Activity
There is no recent news or activity for this profile.